BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36265587)

  • 1. Metal migration and subunit swapping in ALS-linked SOD1: Zn
    Dashnaw CM; Zhang AY; Gonzalez M; Koone JC; Shaw BF
    J Biol Chem; 2022 Dec; 298(12):102610. PubMed ID: 36265587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations.
    Shi Y; Rhodes NR; Abdolvahabi A; Kohn T; Cook NP; Marti AA; Shaw BF
    J Am Chem Soc; 2013 Oct; 135(42):15897-908. PubMed ID: 24066782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gibbs Energy of Superoxide Dismutase Heterodimerization Accounts for Variable Survival in Amyotrophic Lateral Sclerosis.
    Shi Y; Acerson MJ; Abdolvahabi A; Mowery RA; Shaw BF
    J Am Chem Soc; 2016 Apr; 138(16):5351-62. PubMed ID: 27054659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein charge ladders reveal that the net charge of ALS-linked superoxide dismutase can be different in sign and magnitude from predicted values.
    Shi Y; Abdolvahabi A; Shaw BF
    Protein Sci; 2014 Oct; 23(10):1417-33. PubMed ID: 25052939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalation of the amyotrophic lateral sclerosis mutant glycine 37 to arginine superoxide dismutase (SOD1) apoprotein restores its structural and dynamical properties in solution to those of metalated wild-type SOD1.
    Banci L; Bertini I; D'Amelio N; Libralesso E; Turano P; Valentine JS
    Biochemistry; 2007 Sep; 46(35):9953-62. PubMed ID: 17683122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-Induced Misfolding of Zinc-Replete ALS Mutant Superoxide Dismutase-1.
    Shi Y; Acerson MJ; Shuford KL; Shaw BF
    ACS Chem Neurosci; 2015 Oct; 6(10):1696-707. PubMed ID: 26207449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type Cu/Zn superoxide dismutase stabilizes mutant variants by heterodimerization.
    Weichert A; Besemer AS; Liebl M; Hellmann N; Koziollek-Drechsler I; Ip P; Decker H; Robertson J; Chakrabartty A; Behl C; Clement AM
    Neurobiol Dis; 2014 Feb; 62():479-88. PubMed ID: 24200866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of Dueling Cysteine Promotes Subunit Exchange in SOD1.
    Zhang AY; Dashnaw CM; Gonzalez M; Koone JC; Wells NA; Smith CA; Guberman-Pfeffer MJ; Shaw BF
    ACS Chem Neurosci; 2023 Apr; ():. PubMed ID: 37023050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycerolipid Headgroups Control Rate and Mechanism of Superoxide Dismutase-1 Aggregation and Accelerate Fibrillization of Slowly Aggregating Amyotrophic Lateral Sclerosis Mutants.
    Rasouli S; Abdolvahabi A; Croom CM; Plewman DL; Shi Y; Shaw BF
    ACS Chem Neurosci; 2018 Jul; 9(7):1743-1756. PubMed ID: 29649360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural instability and Cu-dependent pro-oxidant activity acquired by the apo form of mutant SOD1 associated with amyotrophic lateral sclerosis.
    Kitamura F; Fujimaki N; Okita W; Hiramatsu H; Takeuchi H
    Biochemistry; 2011 May; 50(20):4242-50. PubMed ID: 21506602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metal loading and subcellular pH on net charge of superoxide dismutase-1.
    Shi Y; Mowery RA; Shaw BF
    J Mol Biol; 2013 Nov; 425(22):4388-404. PubMed ID: 23871896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1.
    Witan H; Gorlovoy P; Kaya AM; Koziollek-Drechsler I; Neumann H; Behl C; Clement AM
    Neurobiol Dis; 2009 Nov; 36(2):331-42. PubMed ID: 19660548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1.
    Brasil AA; de Carvalho MDC; Gerhardt E; Queiroz DD; Pereira MD; Outeiro TF; Eleutherio ECA
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25991-26000. PubMed ID: 31796595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Zn
    Smirnova J; Gavrilova J; Noormägi A; Valmsen K; Pupart H; Luo J; Tõugu V; Palumaa P
    Molecules; 2022 May; 27(10):. PubMed ID: 35630637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation.
    Chattopadhyay M; Nwadibia E; Strong CD; Gralla EB; Valentine JS; Whitelegge JP
    J Biol Chem; 2015 Dec; 290(51):30624-36. PubMed ID: 26511321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
    Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis.
    Tiwari A; Xu Z; Hayward LJ
    J Biol Chem; 2005 Aug; 280(33):29771-9. PubMed ID: 15958382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation.
    Witan H; Kern A; Koziollek-Drechsler I; Wade R; Behl C; Clement AM
    Hum Mol Genet; 2008 May; 17(10):1373-85. PubMed ID: 18211954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase.
    Oztug Durer ZA; Cohlberg JA; Dinh P; Padua S; Ehrenclou K; Downes S; Tan JK; Nakano Y; Bowman CJ; Hoskins JL; Kwon C; Mason AZ; Rodriguez JA; Doucette PA; Shaw BF; Valentine JS
    PLoS One; 2009; 4(3):e5004. PubMed ID: 19325915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.